A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Clinical trial NCT05736419 · RECRUITING
Trial details
- NCT number
- NCT05736419
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2027-02-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.